The new potential application for Mg(II) cysteinedithiocarbamate complex with anticancer activity

Breast Dis. 2023;42(1):177-182. doi: 10.3233/BD-239006.

Abstract

Objective: The new Mg(II) cysteindithiocarbamate complex drug has been synthesized by the in-situ method and tested for its anticancer activity in vitro.

Method: Mg(II) cysteindithiocarbamate complexes were characterized using Ultra Violet Visible, Infra-Red, melting points, and molar conductivity.

Results: The UV-Vis data of cysteindithiocarbamate Mg(II), shows that at 296 nm and 385 nm was occurred the electronic transitions π → π* and n → π* for CS2 and N =C =S. Whereas the IR data at wavelengths in the 393-540 cm-1 shows that there has coordinated between Mg(II) with Sulfur (S), Nitrogen (N), and Oxygen (O) atoms from cysteinedithiocarbamate ligands.

Conclusion: The cytotoxicity test results showed that the Mg complex's cytotoxicity was higher than that of the cytotoxicity of the Mg metal without ligands, which means that the Mg complex can be developed as a potential new anticancer drug.

Keywords: Complex Mg(II); anticancer; breast disease; cytotoxicity.

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Breast Neoplasms*
  • Female
  • Humans
  • Ligands

Substances

  • Ligands
  • Antineoplastic Agents